Kathryn Carr Payne
Directeur/Membre du Conseil chez Massachusetts Biotechnology Council
Profil
Kathryn Carr Payne is currently the Director at Massachusetts Biotechnology Council and Director at March of Dimes Chapter.
She previously worked as Vice President at APCO Worldwide LLC, Vice President-External Affairs at AMAG Pharmaceuticals, Inc., Communications Associate at The World Bank, and Senior VP-Communications & External Affairs at Orchard Therapeutics Plc.
Ms. Payne completed her undergraduate and graduate degrees at The Johns Hopkins University.
Postes actifs de Kathryn Carr Payne
| Sociétés | Poste | Début |
|---|---|---|
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Directeur/Membre du Conseil | - |
| March of Dimes Chapter | Directeur/Membre du Conseil | - |
Anciens postes connus de Kathryn Carr Payne
| Sociétés | Poste | Fin |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Public Communications Contact | 01/08/2018 |
| The World Bank | Public Communications Contact | - |
| ORCHARD THERAPEUTICS PLC | Public Communications Contact | - |
APCO Worldwide LLC
 APCO Worldwide LLC Miscellaneous Commercial ServicesCommercial Services APCO Worldwide LLC engages in the provision of advisory and advocacy communications consultancy solutions. It offers communications, public affairs, government relations, legal, risk, organizational transformation, international relations, corporate responsibility, and brand marketing services. The company was founded by Margery Kraus in 1984 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Formation de Kathryn Carr Payne
| The Johns Hopkins University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
APCO Worldwide LLC
APCO Worldwide LLC Miscellaneous Commercial ServicesCommercial Services APCO Worldwide LLC engages in the provision of advisory and advocacy communications consultancy solutions. It offers communications, public affairs, government relations, legal, risk, organizational transformation, international relations, corporate responsibility, and brand marketing services. The company was founded by Margery Kraus in 1984 and is headquartered in Washington, DC. | Commercial Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| The World Bank | Government |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
| March of Dimes Chapter |
